BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21168168)

  • 21. Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma.
    Minervini A; di Cristofano C; Lapini A; Marchi M; Lanzi F; Giubilei G; Tosi N; Tuccio A; Mancini M; della Rocca C; Serni S; Bevilacqua G; Carini M
    Eur Urol; 2009 Jun; 55(6):1410-8. PubMed ID: 18692300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimally invasive nephron-sparing surgery for renal cell cancer.
    Oakley NE; Hegarty NJ; McNeill A; Gill IS
    BJU Int; 2006 Aug; 98(2):278-84. PubMed ID: 16879665
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor size and nephron-sparing surgery: does it still matter?
    Bensalah K; Crépel M; Patard JJ
    Eur Urol; 2008 Apr; 53(4):691-3. PubMed ID: 18060683
    [No Abstract]   [Full Text] [Related]  

  • 24. High-dose interleukin-2 in metastatic renal cell carcinoma.
    Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
    J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial comment.
    Klatte T
    J Urol; 2009 Dec; 182(6):2606. PubMed ID: 19836796
    [No Abstract]   [Full Text] [Related]  

  • 26. [Surgical treatment for renal cell carcinoma].
    Roos FC; Rübben H; Stief C; Stöckle M; Thüroff JW
    Aktuelle Urol; 2010 Jul; 41(4):252-6. PubMed ID: 20661841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surgical treatment for renal cell carcinoma].
    Roos FC; Rübben H; Stief C; Stöckle M; Thüroff JW
    Dtsch Med Wochenschr; 2010 Feb; 135(6):245-9. PubMed ID: 20127609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cell carcinoma: vena caval involvement.
    Boorjian SA; Sengupta S; Blute ML
    BJU Int; 2007 May; 99(5 Pt B):1239-44. PubMed ID: 17441917
    [No Abstract]   [Full Text] [Related]  

  • 29. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance.
    Lopez-Costea MA; Fumadó L; Lorente D; Riera L; Miranda EF
    BJU Int; 2010 Sep; 106(5):645-8. PubMed ID: 20067450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation of small renal tumors.
    Johnson DB; Cadeddu JA
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):77-83. PubMed ID: 14748659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to the small renal mass: to treat or not to treat.
    Kim SP; Thompson RH
    Urol Clin North Am; 2012 May; 39(2):171-9, vi. PubMed ID: 22487760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Eggener S
    Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Russo P
    Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
    [No Abstract]   [Full Text] [Related]  

  • 34. Minimally invasive therapy for renal cell carcinoma: is there a new community standard?
    Albertsen PC
    J Urol; 2005 Sep; 174(3):869. PubMed ID: 16093976
    [No Abstract]   [Full Text] [Related]  

  • 35. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial comment.
    Uzzo RG
    J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Matthew N. Simmons, Benjamin I. Chung, Inderbir S. Gill. Perioperative efficacy of laparoscopic partial nephrectomy for tumors larger than 4 cm. Eur Urol 2009;55:199-208.
    Baumert H
    Eur Urol; 2009 Jun; 55(6):e103; author reply e104. PubMed ID: 19249152
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinoma and oncocytoma have excellent oncologic outcomes.
    Becker F
    Eur Urol; 2010 Apr; 57(4):666. PubMed ID: 19477584
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
    Lam JS; Breda A; Belldegrun AS; Figlin RA
    J Clin Oncol; 2006 Dec; 24(35):5565-75. PubMed ID: 17158542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kidney parenchyma carcinoma--diagnosis. German Society of Urology].
    Urologe A; 1998 May; 37(3):328-41. PubMed ID: 9646432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.